Overview
Regeneris is a Polish biotechnology company that produces probiotic bacteria in accordance with HACCP and GMP standards, specializing in dried products made from bacteria isolated from human breast milk. It conducts research and development on bacterial strains and their metabolites, including peptides, bacteriocins, and lactic acid. The company develops dietary supplements, functional foods, cosmetics, and preparations to support the treatment of inflammatory conditions and bacterial infections.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 87 days late).
- 202524/03/2026
- 202410/07/2025
- 202305/07/2024
- 202207/07/2023
- 202110/10/2022
- 202015/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
The members of the management board represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Karolina Ziewieckaage 37 | 99 | $2,674.23 | 99% |
Others | 1 | $27.01 | 1% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $1,589,160.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 10, 2026 | Aid for research and development projects: industrial research | –– | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Mar 10, 2026 | Aid for research and development projects: experimental development | –– | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Feb 9, 2026 | Aid for research and development projects: experimental development | –– | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-01-01 | Biopreparations containing natural antibacterial substances as an alternative to antibiotic therapy | $818.6K$818,562 | European Funds for a Modern Economy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biolive Innovationsp. z o.o. | $843,048.16 | bioliveinnovation.pl | ||
| Bioticfoodssp. z o.o. | $745,953.17 | bioticfoods.pl | ||
| Holistic Labssp. z o.o. | $606,899.51 | holistic-labs.com.pl | ||
| Colostrum Polskasp. z o.o. | $587,012.72 | colostrumpolska.pl | ||
| Nexon Pharmasp. z o.o. | $574,250.90 | nexonpharma.pl | ||
| Colbiomsp. z o.o. | $534,562.65 | colbiom.pl | ||
| Agrapaksp. z o.o. | $459,325.93 | agrapak.pl | ||
| BiofusionS.A. | $171,189.01 | biofusion.io | ||
| Drinks of Lifesp. z o.o. | $132,426.83 | drinksoflife.com | ||
| Nutrideasp. z o.o. | $110,940.30 | nutridea.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-10-16 | Address change (45, 26-060, Podzamcze → Ul. Bukowa 2, 26-060, Bilcza) | |
| 2024-05-09 | Address change (Ul. Skrajna 80 D, 25-650, Kielce → 45, 26-060, Podzamcze) | |
| 2023-12-18 | Address change (Ul. Generała Tadeusza Kościuszki 25e, 25-316, Kielce → Ul. Skrajna 80 D, 25-650, Kielce) | |
| 2023-07-25 | Address change (Ul. Robotnicza 1/904, 25-662, Kielce → Ul. Generała Tadeusza Kościuszki 25e, 25-316, Kielce) | |
| 2015-11-30 | Entered in the register |
FAQ
Last updated: 2026-10-18